More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History

Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History

by adminAdrianRamirez | May 3, 2018 | HempMeds, Kannaway, Press Releases

SAN DIEGO, May 3, 2018  — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that both the Company and its subsidiary Kannaway®, have booked their largest-ever (unaudited) sales revenue in...
Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History

Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights – Annual Revenue Increased 230% Over 2016

by adminAdrianRamirez | Apr 18, 2018 | HempMeds, Kannaway, Press Releases

SAN DIEGO, April 18, 2018 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced financial results for the quarter and year ending December 31, 2017 and provided an overview of recent...
Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Active Relief Roll-On Product at Pittsburgh World Medical Cannabis Conference & Expo

Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Active Relief Roll-On Product at Pittsburgh World Medical Cannabis Conference & Expo

by adminAdrianRamirez | Apr 12, 2018 | HempMeds, Press Releases

SAN DIEGO, April 12, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has released a new topical hemp product, its Active Relief Roll-On, at...
Medical Marijuana, Inc. Subsidiary HempMeds® to Sponsor and Exhibit at 2018 World Medical Cannabis Conference & Expo

Medical Marijuana, Inc. Subsidiary HempMeds® to Sponsor and Exhibit at 2018 World Medical Cannabis Conference & Expo

by adminAdrianRamirez | Apr 10, 2018 | HempMeds, Press Releases

Medical Marijuana, Inc. CEO to Speak on the Benefits of CBD at International Industry Event SAN DIEGO, April 10, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its...
Washington Post, Chicago Tribune, Cannabist, and Epicurious Highlight Medical Marijuana, Inc. Family of Companies

Washington Post, Chicago Tribune, Cannabist, and Epicurious Highlight Medical Marijuana, Inc. Family of Companies

by adminAdrianRamirez | Apr 6, 2018 | HempMeds, HempMeds Mexico, Media Coverage

Medical Marijuana, Inc. continues to drive the conversation surrounding the booming CBD market in the U.S. and internationally. Major media outlets, representing millions of views a month, featured Medical Marijuana, Inc. and our portfolio of companies and CBD oil...
Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™ Featured on CBS’ The Doctors

Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™ Featured on CBS’ The Doctors

by adminAdrianRamirez | Mar 29, 2018 | HempMeds, Press Releases, Real Scientific Hemp Oil

SAN DIEGO, March 29, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its flagship product Real Scientific Hemp Oil™ (RSHO™) was featured on Emmy® Award-winning daytime...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.